Showing results (1411-1420 of 1,532) with videos related to

Sort By:
Pageof 154
Biologicals : Journal of the International Association of Biological Standardization|March 22, 2024
Standards for fecal microbiota transplant: Tools and therapeutic advancesIlia Belotserkovsky, Lisa M Stabryla, Monique Hunter, et al.
Elife|June 20, 2019
Silencing cryptic specialized metabolism in <i>Streptomyces</i> by the nucleoid-associated protein Lsr2Emma J Gehrke, Xiafei Zhang, Sheila M Pimentel-Elardo, et al.
Scientific Reports|May 27, 2018
Long-Term Administration of Conjugated Estrogen and Bazedoxifene Decreased Murine Fecal β-Glucuronidase Activity Without Impacting Overall Microbiome CommunityKaren Lee Ann Chen, Xiaoji Liu, Yiru Chen Zhao, et al.
JAMA Health Forum|September 13, 2024
A Machine Learning Method for Allocating Scarce COVID-19 Monoclonal AntibodiesMengli Xiao, Kyle C Molina, Neil R Aggarwal, et al.
Eclinicalmedicine|July 26, 2021
Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trialSusan E Carlson, Byron J Gajewski, Christina J Valentine, et al.
Nature Methods|April 20, 2021
Geometric deep learning enables 3D kinematic profiling across species and environmentsTimothy W Dunn, Jesse D Marshall, Kyle S Severson, et al.
Nature Communications|April 6, 2024
Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine modelJulia D Berkson, Claire E Wate, Garrison B Allen, et al.
Molecular Biology and Evolution|May 19, 2016
Positive Selection on a Regulatory Insertion-Deletion Polymorphism in FADS2 Influences Apparent Endogenous Synthesis of Arachidonic AcidKumar S D Kothapalli, Kaixiong Ye, Maithili S Gadgil, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 21, 2023
Early and late preterm birth rates in participants adherent to randomly assigned high dose docosahexaenoic acid (DHA) supplementation in pregnancyS E Carlson, B J Gajewski, C J Valentine, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2021
Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation CyclesSabrina Fechtner, Heather Berens, Elizabeth Bemis, et al.
Pageof 154